ANDA 204503, held by Dr Reddys. Zolpidem Tartrate.
As of Nov 16, 2026, ANDA 204503 (Zolpidem Tartrate), held by Dr Reddys, was first approved by FDA on Nov 18, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 18, 2016 | Original application | Approved | None posted |
| Zolpidem Tartrate1.75MG · tablet;sublingual | Zolpidem Tartrate | Rx |
| Zolpidem Tartrate3.5MG · tablet;sublingual | Zolpidem Tartrate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters